ロード中...
Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for causing coronavirus disease 2019 (COVID-19), marked the third time in the twenty-first century when a new, highly pathogenic human coronavirus outbreak has led to an epidemic. The COVID-19 epidemic has...
保存先:
| 出版年: | Curr Pharmacol Rep |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7367788/ https://ncbi.nlm.nih.gov/pubmed/32837854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40495-020-00226-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|